Peter Geschek
Peter Geschek
Stop FollowingPeter Geschek
View as an RSS Feed
View Peter Geschek's Articles BY TICKER:
- Bristol-Myers Squibb's Dividend Increase And Promising New Drugs
- Express Scripts And Competition In Pharma Benefits
- Pfizer On The Move: A Rise In Dividend, Precious Approvals Gained
- Celgene's Long-Term Plan For Generating Blockbusters
- CVS Caremark's Dividend Increase And The Facts Behind It
- Amgen On The Move: Raising Dividend, Expanding Pipeline
- Edwards Lifesciences' Very Good Year
- Ariad's Wonder Drug For Leukemia Patients
- Gilead Sciences' Stock Dividend And What's Behind It
- Pharmacyclics And Promising Advances In Leukemia Treatment
- Gilead Sciences Leads The Race In Developing A Hepatitis C Pill
- Pfizer And Bristol's Search For Antidote To Blood Thinners And Lawsuits
- Exelixis's Promising Pipeline Of Drugs
- Politically Favored Hospital Stocks
- High Stake Search For The Next Lipitor
- The Booming Business Of Medicaid
- How Safe Is Amgen's Dividend?
- The Generics Empire Of Watson Pharma Soon To Be Named Actavis
- Giant Intuitive Surgical Moves Into New Types Of Surgeries
- Johnson & Johnson's Rising Dividend And The Facts Behind It
- How Big A Dividend Will Abbott Pay After It Splits?
- Medtronic's Revolutionary Device To Control High Blood Pressure
- Biogen Idec And The Race To Cure Multiple Sclerosis
- Eli Lilly And The State Of The Insulin Battle
-
Investing In Novel Drug Delivery Ideas
- Bristol-Myers Squibb And The Promise Of Cancer Immunotherapy
- Boston Scientific's Device To Relieve Severe Asthma: A Major Opportunity
- Amgen And Its Biosimilar Competitors
- The Race To Help Stroke Victims: New Devices
- Merck's Blockbuster Drug Januvia And Its Competitors
-
Edwards Lifesciences And The Booming Heart Valve Business
- The Race To Cure PAD, Peripheral Artery Disease
